Suppr超能文献

HIV-1 融合蛋白的免疫调节基序是手性非依赖性的:对其作用模式的影响。

An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.

机构信息

From the Departments of Biological Chemistry and.

出版信息

J Biol Chem. 2013 Nov 15;288(46):32852-60. doi: 10.1074/jbc.M113.512038. Epub 2013 Sep 27.

Abstract

An immunosuppressive motif was recently found within the HIV-1 gp41 fusion protein (termed immunosuppressive loop-associated determinant core motif (ISLAD CM)). Peptides containing the motif interact with the T-cell receptor (TCR) complex; however, the mechanism by which the motif exerts its immunosuppressive activity is yet to be determined. Recent studies showed that interactions between protein domains in the membrane milieu are not always sterically controlled. Therefore, we utilized the unique membrane leniency toward association between D- and L-stereoisomers to investigate the detailed mechanism by which ISLAD CM inhibits T-cell activation. We show that a D-enantiomer of ISLAD CM (termed ISLAD D-CM) inhibited the proliferation of murine myelin oligodendrocyte glycoprotein (MOG)-(35-55)-specific line T-cells to the same extent as the l-motif form. Moreover, the D- and L-forms preferentially bound spleen-derived T-cells over B-cells by 13-fold. Furthermore, both forms of ISLAD CM co-localized with the TCR on activated T-cells and interacted with the transmembrane domain of the TCR. FRET experiments revealed the importance of basic residues for the interaction between ISLAD CM forms and the TCR transmembrane domain. Ex vivo studies demonstrated that ISLAD D-CM administration inhibited the proliferation (72%) and proinflammatory cytokine secretion of pathogenic MOG(35-55)-specific T-cells. This study provides insights into the immunosuppressive mechanism of gp41 and demonstrates that chirality-independent interactions in the membrane can take place in diverse biological systems. Apart from HIV pathogenesis, the D-peptide reported herein may serve as a potential tool for treating T-cell-mediated pathologies.

摘要

最近在 HIV-1 gp41 融合蛋白中发现了一个免疫抑制基序(称为免疫抑制环相关决定簇核心基序(ISLAD CM))。含有该基序的肽与 T 细胞受体(TCR)复合物相互作用;然而,该基序发挥免疫抑制活性的机制尚不清楚。最近的研究表明,膜环境中蛋白质结构域之间的相互作用并不总是受空间位阻控制。因此,我们利用 D-和 L-对映异构体在膜环境中关联的独特柔韧性,研究了 ISLAD CM 抑制 T 细胞活化的详细机制。我们表明,ISLAD CM 的 D-对映异构体(称为 ISLAD D-CM)抑制了小鼠髓鞘少突胶质细胞糖蛋白(MOG)-(35-55)-特异性 T 细胞的增殖,其程度与 l 基序形式相同。此外,D-和 L-形式优先通过 13 倍结合脾衍生的 T 细胞而不是 B 细胞。此外,两种形式的 ISLAD CM 与激活的 T 细胞上的 TCR 共定位,并与 TCR 的跨膜结构域相互作用。FRET 实验表明,碱性残基对于 ISLAD CM 形式与 TCR 跨膜结构域之间的相互作用很重要。离体研究表明,ISLAD D-CM 给药抑制了致病性 MOG(35-55)-特异性 T 细胞的增殖(72%)和促炎细胞因子的分泌。这项研究深入了解了 gp41 的免疫抑制机制,并表明在不同的生物系统中可以发生膜中非手性相互作用。除了 HIV 发病机制外,本文报道的 D-肽可能可作为治疗 T 细胞介导的病理学的潜在工具。

相似文献

1
An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.
J Biol Chem. 2013 Nov 15;288(46):32852-60. doi: 10.1074/jbc.M113.512038. Epub 2013 Sep 27.
2
A highly conserved sequence associated with the HIV gp41 loop region is an immunomodulator of antigen-specific T cells in mice.
Blood. 2013 Mar 21;121(12):2244-52. doi: 10.1182/blood-2012-11-468900. Epub 2013 Jan 16.
4
6
The HIV gp41 Fusion Protein Inhibits T-Cell Activation through the Lentiviral Lytic Peptide 2 Motif.
Biochemistry. 2019 Feb 12;58(6):818-832. doi: 10.1021/acs.biochem.8b01175. Epub 2019 Jan 15.
7
HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.
J Clin Invest. 2005 Aug;115(8):2149-58. doi: 10.1172/JCI23956. Epub 2005 Jul 7.
10
T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif.
FASEB J. 2007 Feb;21(2):393-401. doi: 10.1096/fj.06-7061com. Epub 2006 Dec 21.

引用本文的文献

1
Mycoplasma genitalium Protein of Adhesion Suppresses T Cell Activation via CypA-CaN-NFAT Pathway.
Microbiol Spectr. 2023 Jun 15;11(3):e0450322. doi: 10.1128/spectrum.04503-22. Epub 2023 Apr 19.
2
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.
PLoS Pathog. 2018 May 4;14(5):e1007044. doi: 10.1371/journal.ppat.1007044. eCollection 2018 May.
3
Peptides and peptidomimetics as immunomodulators.
Immunotherapy. 2014;6(6):755-74. doi: 10.2217/imt.14.37.

本文引用的文献

1
HIV-1 fusion protein exerts complex immunosuppressive effects.
Trends Biochem Sci. 2013 Jul;38(7):345-9. doi: 10.1016/j.tibs.2013.04.003. Epub 2013 May 17.
2
Assembly of the TLR2/6 transmembrane domains is essential for activation and is a target for prevention of sepsis.
J Immunol. 2013 Jun 15;190(12):6410-22. doi: 10.4049/jimmunol.1202033. Epub 2013 May 15.
3
A highly conserved sequence associated with the HIV gp41 loop region is an immunomodulator of antigen-specific T cells in mice.
Blood. 2013 Mar 21;121(12):2244-52. doi: 10.1182/blood-2012-11-468900. Epub 2013 Jan 16.
5
Recent advances in antiretroviral treatment and prevention in HIV-infected patients.
Curr Opin HIV AIDS. 2011 Dec;6 Suppl 1:S21-30. doi: 10.1097/01.COH.0000410238.80894.81.
6
Transmembrane domains interactions within the membrane milieu: principles, advances and challenges.
Biochim Biophys Acta. 2012 Apr;1818(4):974-83. doi: 10.1016/j.bbamem.2011.11.029. Epub 2011 Dec 3.
7
Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41.
FASEB J. 2011 Jul;25(7):2156-66. doi: 10.1096/fj.10-175752. Epub 2011 Mar 23.
9
Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.
Cell Host Microbe. 2010 Jul 22;8(1):55-67. doi: 10.1016/j.chom.2010.06.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验